Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$300,432
+$54,810 QoQ
Shares Held
1,917
+19.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,134
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $3,156,802,100 across 12 Drug Manufacturers - General names. NVS ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,343,260 | $1,357,027,741 | |
| 2 | AZN |
Astrazeneca PLC
|
5,021,518 | $952,180,243 | |
| 3 | LLY |
ELI LILLY & Co
|
483,528 | $579,958,037 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,088,957 | $137,578,827 | |
| 5 | MRK |
Merck & Co., Inc.
|
565,690 | $72,691,165 | |
| 6 | AMGN |
Amgen Inc
|
69,065 | $25,009,817 | |
| 7 | ABBV |
AbbVie Inc.
|
82,422 | $20,740,672 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,597 | $5,854,019 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,432 | 1,917 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $245,622 | 1,608 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $221,970 | 1,610 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $269,432 | 2,101 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $284,494 | 2,351 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $262,089 | 2,351 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $228,775 | 2,351 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $270,412 | 2,351 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $250,287 | 2,351 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $227,412 | 2,351 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $262,118 | 2,596 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $368,427 | 3,617 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $299,904 | 2,972 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $273,884 | 2,977 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $271,071 | 2,988 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $219,668 | 2,890 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $679,029 | 8,033 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $730,518 | 8,325 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,438,883 | 39,315 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,335,887 | 40,791 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,217,396 | 35,263 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,215,672 | 37,619 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $148,928,574 | 1,577,132 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $136,461,023 | 1,569,239 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $164,546,376 | 1,883,975 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $154,987,366 | 1,879,774 | Shares | Defined | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||